MedTrace Logo

Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia

NCT03636867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2023-03-24

No results posted yet for this study

Summary

The ECAD-CLI is an investigator-driven, prospective, single-center study. The aim of the study is to prospectively collect clinical, laboratory, angiographic, cellular and molecular variables related to prognosis and outcome in patients with diabetes mellitus and critical limb ischemia.

Conditions

  • Diabetes Mellitus
  • Critical Limb Ischemia
  • Critical Lower Limb Ischemia
  • Diabetic Foot

Interventions

OTHER

data and specimen collection

to identify laboratory, cellular and molecular determinants of clinical success after treatment, several clinical information and specimens will be collected by Authors from each patient

Sponsors & Collaborators

  • Maria Cecilia Hospital

    lead OTHER

Principal Investigators

  • Luca Dalla Paola, MD · Maria Cecilia Hospital

  • Gianluca Campo, MD · Università degli Studi di Ferrara

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-07
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03636867 on ClinicalTrials.gov